Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response.
William StevensIsabelle M FarrowLeonidas GeorgiouAndrew M HanbyTimothy J PerrenLaura M WindelDaniel J WilsonNisha SharmaDavid DodwellThomas A HughesBarbara Jg DallDavid L BuckleyPublished in: The British journal of radiology (2021)
The change in breast tumour blood flow following one cycle of EC90 did not predict pathological response. Tumour volume may be a better early marker of response with such agents.